Cargando…

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

INTRODUCTION: Preventing tuberculosis (TB) disease requires treatment of latent TB infection (LTBI) as well as prevention of person-to-person transmission. We estimated the LTBI prevalence for the entire United States and for each state by medical risk factors, age, and race/ethnicity, both in the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirzazadeh, Ali, Kahn, James G., Haddad, Maryam B., Hill, Andrew N., Marks, Suzanne M., Readhead, Adam, Barry, Pennan M., Flood, Jennifer, Mermin, Jonathan H., Shete, Priya B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016318/ https://www.ncbi.nlm.nih.gov/pubmed/33793612 http://dx.doi.org/10.1371/journal.pone.0249012

Ejemplares similares

Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014–2017
por: Readhead, Adam, et al.
Publicado: (2022)

Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California
por: Bakhsh, Yasser, et al.
Publicado: (2022)

Outlook for tuberculosis elimination in California: An individual-based stochastic model
por: Goodell, Alex J., et al.
Publicado: (2019)

Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016
por: Vaisman, Alon, et al.
Publicado: (2020)

Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act
por: Ehman, Melissa, et al.
Publicado: (2014)

Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015
por: Haddad, Maryam B., et al.
Publicado: (2018)

1392. Tuberculosis Disease in Recipients of Organ-Transplantation, California 2010–2017
por: Katrak, Shereen, et al.
Publicado: (2019)

Death With Tuberculosis in California, 1994–2008
por: Pascopella, Lisa, et al.
Publicado: (2014)

Getting to Zero: Tuberculosis Elimination in California
por: Barry, Pennan M., et al.
Publicado: (2016)

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015
por: Oh, Peter, et al.
Publicado: (2017)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Economic analyses to inform public health decision-making for tuberculosis: the role of understanding implementation
por: Shete, Priya B., et al.
Publicado: (2019)

Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States()
por: Belanger, Annie, et al.
Publicado: (2019)

Tuberculosis Outbreak Investigations in the United States, 2002–2008
por: Mitruka, Kiren, et al.
Publicado: (2011)

Tuberculosis Among Native Hawaiian and Other Pacific Islander Persons: United States and U.S.-Affiliated Pacific Islands, 2010–2019
por: Deutsch-Feldman, Molly, et al.
Publicado: (2022)

The ongoing challenge of latent tuberculosis
por: Esmail, H., et al.
Publicado: (2014)

1881. Costs of Treating Multidrug Resistant Tuberculosis in California, 2022
por: Katrak, Shereen, et al.
Publicado: (2023)

Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis
por: Parriott, Andrea, et al.
Publicado: (2018)

Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010–2013
por: Peralta, Gianna, et al.
Publicado: (2016)

Birth cohort effect on latent tuberculosis infection prevalence, United States
por: Winston, Carla A, et al.
Publicado: (2010)

Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic
por: Dobler, Claudia C., et al.
Publicado: (2012)

Solid state physics
por: Ashcroft, Neil W, et al.
Publicado: (1976)

Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review
por: Malekinejad, Mohsen, et al.
Publicado: (2017)

Characteristics of Tuberculosis Cases that Started Outbreaks in the United States, 2002–2011
por: Haddad, Maryam B., et al.
Publicado: (2015)

Correction: Completion of Treatment for Latent Tuberculosis Infection with Monthly Drug Dispensation Directly through the Tuberculosis Clinic
por: Dobler, Claudia C., et al.
Publicado: (2013)

What Patient Factors Predict Physicians’ Decision Not to Treat Latent Tuberculosis Infection in Tuberculosis Contacts?
por: Dobler, Claudia C., et al.
Publicado: (2013)

Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
por: Vonnahme, Laura A., et al.
Publicado: (2019)

Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999–2012
por: Vozoris, Nicholas T., et al.
Publicado: (2016)

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States
por: Winston, Carla A., et al.
Publicado: (2023)

Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review
por: Parriott, Andrea, et al.
Publicado: (2018)

Measuring success: The challenge of social protection in helping eliminate tuberculosis
por: Shete, Priya B., et al.
Publicado: (2017)

Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010–2012
por: Demlow, Sarah Ellen, et al.
Publicado: (2015)

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California
por: Blount, Robert J., et al.
Publicado: (2017)

Groundwater Storage Trends and Their Link to Farmer Suicides in Maharashtra State, India
por: Chinnasamy, Pennan, et al.
Publicado: (2019)

Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review
por: Miller, Amanda P., et al.
Publicado: (2019)

Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States
por: Menzies, Nicolas A., et al.
Publicado: (2020)

Treatment Practices, Outcomes, and Costs of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, United States, 2005–2007
por: Marks, Suzanne M., et al.
Publicado: (2014)

Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017)

Finding and treating both tuberculosis disease and latent infection during population-wide active case finding for tuberculosis elimination
por: Coleman, Mikaela, et al.
Publicado: (2023)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
por: Katrak, Shereen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cd4828c9icoi0vd3ust3b8e9oj